Perimenopause: not low estrogen — chaotic estrogen
"But my estrogen is fine — my labs look normal." This is one of the most common things we hear. And it makes sense to wonder: if I still have estrogen, why do I feel so terrible? Here's what's actually going on.
Perimenopause is not about low estrogen. It's about chaotic estrogen.
For most of your adult life, your hormones followed a rhythm. Estrogen rose and fell in a predictable pattern each month. Your brain and body knew what was coming. They could respond and adapt. That rhythm is what made everything work smoothly — mood, sleep, temperature regulation, energy, concentration.
In perimenopause, that rhythm breaks down. The ovaries start becoming less reliable — some months they ovulate normally, some months they don't, some months they produce a surge of estrogen that's actually higher than what you'd have had in your thirties. Your hormone levels stop being predictable. They spike, crash, spike again. Sometimes within the same week.
This is the hormonal roller coaster that women describe. And the important thing to understand is that the symptoms — hot flashes, mood swings, poor sleep, brain fog, anxiety — are driven by that volatility, not just by low estrogen. Your brain and body have lost their footing. They no longer know what to expect from one day to the next.
So why does estrogen therapy help?
This is the question that confuses a lot of women — especially when they've had a blood test that showed normal or even high estrogen. If I have estrogen, why would I take more?
The answer is that estrogen therapy works by providing a steady, stable signal — not by raising your levels higher. Think of it like a rocking boat. The problem isn't the water level, it's the rocking. Hormone therapy calms the rocking. It gives your brain a consistent hormonal environment to work with, rather than the chaos it's been trying to navigate.
Research confirms this. In studies measuring estrogen levels during treatment, the benefit to symptoms wasn't about achieving high levels — it came from stabilization. Women felt better because the unpredictable swings stopped, not because their estrogen was raised to some ideal number. The same is true for why a single blood test can be so misleading — it only captures what your hormones were doing at that one moment. It tells you nothing about the swings.
Why symptoms can start before your periods change
One of the most disorienting parts of perimenopause is that symptoms can begin years before your cycle becomes irregular. You might be having completely normal periods and still be experiencing hot flashes, mood changes, and disrupted sleep. This makes it very easy for symptoms to go unrecognized — or dismissed — because on paper everything looks fine.
What's happening underneath is that the hormonal variability starts before the menstrual cycle reflects it. The ovaries are already becoming less consistent in their output. The brain's ability to respond to estrogen is already shifting. The symptoms are real and hormonal — they're just ahead of the calendar. Perimenopause can begin up to a decade before the final period.
The long view: what early treatment protects
Beyond symptom relief, starting hormone therapy during the perimenopause window — rather than waiting until years after menopause — matters for long-term health. This is what researchers call the timing hypothesis, and the evidence behind it is substantial.
- Bone. Estrogen is one of the primary things that keeps bones dense. Without it, bone loss accelerates after menopause. Estrogen therapy started early significantly reduces fracture risk — including hip and spine fractures that can have serious long-term consequences.
- Metabolism. Estrogen influences how the body manages blood sugar and fat storage. Women who start hormone therapy early have lower rates of developing diabetes and experience less of the abdominal fat accumulation that drives cardiovascular risk.
- Heart. The menopausal transition itself is a cardiovascular transition. Estrogen loss changes how blood vessels function, how cholesterol behaves, and how fat is distributed. Starting treatment early — during perimenopause or within ten years of the final period — is associated with more favorable cardiovascular outcomes than starting later.
The sources behind this page
- Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021.
- Joffe H, de Wit A, Coborn J, et al. Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women. J Clin Endocrinol Metab. 2020.
- Avis NE, Crawford SL, Greendale G, et al. Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition. JAMA Intern Med. 2015.
- Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023;329(5):405-420.
- Ensrud KE, Larson JC, Guthrie KA, et al. Changes in Serum Endogenous Estrogen Concentrations Are Mediators of the Effect of Low-Dose Oral Estradiol on Vasomotor Symptoms. Menopause. 2022.
- El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause Transition and Cardiovascular Disease Risk. Circulation. 2020.
- Gartlehner G, Patel SV, Reddy S, et al. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: USPSTF Evidence Review. JAMA. 2022.
- Duralde ER, Sobel TH, Manson JE. Management of Perimenopausal and Menopausal Symptoms. BMJ. 2023.
- Aras SG, Grant AD, Konhilas JP. Clustering of >145,000 Symptom Logs Reveals Distinct Pre, Peri, and Menopausal Phenotypes. Scientific Reports. 2025.

